Clinical guidelines for depressive disorders in childhood and adolescence

European Child and Adolescent Psychiatry

Volumn 9, Issue 3, 2000, Pages 147-161

  Park, R J ^a   Goodyer, I M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antidepressant medication; Child adolescent depression; Psychotherapy; Treatment

Indexed keywords

CLINICAL PRACTICE; CLINICAL PROTOCOL; DEPRESSION; HUMAN; MEDICAL RESEARCH; REVIEW; TREATMENT PLANNING;

EID: 0033782841     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007870070038     Document Type: Review

References (76)

1. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders
2. The epidemiology of depression in children and adolescents
3. Depressive comorbidity in children and adolescents: Empirical, theoretical, and methodological issues
4. Puberty and depression: The roles of age, pubertal status and pubertal timing
5. Parent and child reports of depressive symptoms in children at low and high risk of depression
6. A clinical trial for adolescent depression: Predictors of additional treatment in the acute and follow-up phases of the trial
7. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression
8. Developmental psychopathology and disorders of affect
9. Withdrawing patients from antidepressants
10. Structured interviewing
11. Scales to assess child and adolescent depression: Checklists, screens, and nets
12. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
13. Nontricyclic antidepressants: Current trends in children and adolescents
14. Increased rates of depression: Update of epidemiological findings and analytical problems
15. Critical review of tricyclic antidepressant use in children and adolescents
16. Life events and difficulties: Their nature and effects
17. Recent undesirable life events: Their influence on subsequent psychopathology
18. Temperament and major depression in 11 to 16 year olds
19. A community study of depression in adolescent girls. II. The clinical features of identified disorder
20. Adrenal steroid secretion and major depression in 8- to 16-year-olds. III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression
21. Short-term outcome of major depression. I. Comorbidity and severity at presentation as predictors of persistent disorder
22. Short-term outcome of major depression. II. Life events, family dysfunction, and friendship difficulties as predictors of persistent disorder
23. Development of a rating scale for primary depressive illness
24. The context of depression in clinic-referred youth: Neglected areas in treatment
25. Adult outcomes of childhood and adolescent depression. III. Links with suicidal behaviours
26. Adult outcomes of childhood and adolescent depression. I. Psychiatric status
27. Adult outcomes of childhood and adolescent depression. II. Links with antisocial disorders
28. Developmental pathways in depression: Multiple meanings, antecedents and endpoints
29. Psychological treatment of depression in children and adolescents
30. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder
31. Cognitive therapy for depression in children and adolescents
32. Fortnightly review. Stress, the brain, and mental illness
33. Adrenal secretion and major depression in 8- to 16-year-olds. II. Influence of comorbidity at presentation
34. Which depressed patients respond to cognitive-behavioural treatment?
35. Schedule for affective disorder and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data
36. Anna-Monika-Prize paper. Major depression and the environment: A psychiatric genetic perspective
37. Presentation and course of major depressive disorder during childhood and later years of the life span
38. The Emanuel Miller Memorial Lecture 1994. Depressive disorders in childhood: An impressionistic landscape
39. Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome
40. Secular trends in age at onset of major depressive disorder in a clinical sample of children
41. Depressive disorders in childhood. IV. A longitudinal study of comorbidity with and risk for anxiety disorders
42. First-episode major depressive and dysthymic disorder in childhood: Clinical and sociodemographic factors in recovery
43. Depressive disorders in childhood. III. A longitudinal study of comorbidity with and risk for conduct disorders
44. Pilot study of continuation cognitive-behavioural therapy for major depression in adolescent psychiatric patients
45. Practitioner review: The pharmacotherapy of adolescent depression
46. Psychosocial treatments for adolescent depression
47. Natural course of adolescent major depressive disorder. I. Continuity into young adulthood
48. Venlafaxine in the treatment of children and adolescents with major depression
49. Diagnostic utility of the beck depression inventory with adolescent psychiatric outpatients and inpatients
50. Newer antidepressants. Beyond selective serotonin reuptake inhibitor antidepressants
51. Modification of interpersonal psychotherapy with depressed adolescents (IPT-A): Phase I and II studies
52. Efficacy of interpersonal psychotherapy for depressed adolescents
53. The emergence of gender differences in depression during adolescence
54. Predictors and consequences of childhood depressive symptoms: A 5-year longitudinal study
55. Emergent properties of neural systems: How focal molecular neurobiological alterations can affect behavior
56. Child and adolescent mood disorders-experience with serotonin-based therapies
57. Differential cognitive response to a mood challenge following successful cognitive therapy or pharmacotherapy for unipolar depression
58. A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder
59. The effectiveness of psychotherapy. The consumer reports study
60. A children's global assessment scale (CGAS)
61. Suicide and attempted suicide
62. The pharmacotherapy of depressive illness in adolescents: An open-label comparison of fluoxetine with imipramine-treated historical controls
63. Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy
64. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder
65. Family functioning and parent general health in families of adolescents with major depressive disorder
66. Cognitive vulnerability to persistent depression
67. Children with prepubertal-onset major depressive disorder and anxiety grown up
68. Sex differences in rates of depression: Cross-national perspectives
69. Interpersonal psychotherapy. Current status
70. Depressed adolescents grown up